Citigroup’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-123,653
Closed -$270K 4800
2024
Q1
$270K Buy
+123,653
New +$270K ﹤0.01% 3159
2022
Q4
Sell
-795
Closed -$1K 4959
2022
Q3
$1K Sell
795
-882
-53% -$1.11K ﹤0.01% 4787
2022
Q2
$3K Sell
1,677
-2,648
-61% -$4.74K ﹤0.01% 4973
2022
Q1
$11K Sell
4,325
-126,444
-97% -$322K ﹤0.01% 4689
2021
Q4
$566K Buy
130,769
+21,300
+19% +$92.2K ﹤0.01% 2965
2021
Q3
$557K Sell
109,469
-191,688
-64% -$975K ﹤0.01% 2812
2021
Q2
$1.91M Buy
301,157
+97,002
+48% +$614K ﹤0.01% 2130
2021
Q1
$1.58M Buy
204,155
+192,708
+1,683% +$1.49M ﹤0.01% 2077
2020
Q4
$75K Buy
11,447
+6,667
+139% +$43.7K ﹤0.01% 3863
2020
Q3
$32K Sell
4,780
-32,778
-87% -$219K ﹤0.01% 3714
2020
Q2
$313K Buy
37,558
+20,595
+121% +$172K ﹤0.01% 2840
2020
Q1
$130K Buy
16,963
+3,350
+25% +$25.7K ﹤0.01% 3127
2019
Q4
$113K Sell
13,613
-23,428
-63% -$194K ﹤0.01% 3466
2019
Q3
$273K Sell
37,041
-54,947
-60% -$405K ﹤0.01% 2911
2019
Q2
$1.03M Buy
91,988
+63,384
+222% +$711K ﹤0.01% 2117
2019
Q1
$307K Sell
28,604
-101,904
-78% -$1.09M ﹤0.01% 2836
2018
Q4
$1.97M Buy
130,508
+97,215
+292% +$1.47M ﹤0.01% 1546
2018
Q3
$616K Sell
33,293
-9,935
-23% -$184K ﹤0.01% 2364
2018
Q2
$988K Buy
43,228
+11,505
+36% +$263K ﹤0.01% 1886
2018
Q1
$902K Sell
31,723
-6,104
-16% -$174K ﹤0.01% 1880
2017
Q4
$799K Buy
37,827
+22,984
+155% +$485K ﹤0.01% 2038
2017
Q3
$270K Buy
14,843
+14,768
+19,691% +$269K ﹤0.01% 2799
2017
Q2
$1K Sell
75
-382
-84% -$5.09K ﹤0.01% 4677
2017
Q1
$8K Sell
457
-20,201
-98% -$354K ﹤0.01% 4339
2016
Q4
$227K Buy
20,658
+18,875
+1,059% +$207K ﹤0.01% 3492
2016
Q3
$28K Sell
1,783
-383
-18% -$6.02K ﹤0.01% 4022
2016
Q2
$22K Sell
2,166
-4,115
-66% -$41.8K ﹤0.01% 4136
2016
Q1
$81K Buy
6,281
+3,969
+172% +$51.2K ﹤0.01% 4048
2015
Q4
$48K Buy
+2,312
New +$48K ﹤0.01% 4093